Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.
Precision Oncology's Next Challenge in India: Identifying HER2-Low Patients at Scale
As drugs like Enhertu expand into HER2-low breast cancer, India's fragmented pathology infrastructure makes consistent biomarker identification a structural bottleneck,...
PAICON at HLTH Europe: Data Equity Takes Center Stage in Amsterdam
At HLTH Europe, our CEO Dr. Manasi Aichmüller-Ratnaparkhe joined a data equity panel to argue that the barrier to closing...
Why Medical AI Doesn't Travel: Building Data Systems That Cross Borders
Medical AI models often lose accuracy at new hospitals not because the model is flawed, but because the underlying data...
PAICON at bio:cap Europe: Bringing PaiX Navigator to Berlin
PAICON brought PaiX Navigator to bio:cap Europe in Berlin, where CEO Dr. Manasi Aichmüller-Ratnaparkhe took the Startup Stage to introduce...
PAICON is Taking the Stage at HLTH Europe
PAICON is taking the stage at HLTH Europe 2026 in Amsterdam, June 15–18. Our CEO Dr. Manasi Aichmueller-Ratnaparkhe joins the...
The Clock is Running Before the Science Even Starts
Before the science can start, the clock is already running. This piece examines why data access is the most cited...
Meet PAICON at bio:cap Europe 2026 in Berlin
PAICON is heading to bio:cap Europe 2026 in Berlin. Book a meeting with our team for an exclusive PaiX Navigator...
Designing Globally Scalable Oncology Data Systems
As the global cancer burden approaches 35 million new cases by 2050, building AI systems that reliably work across diverse...
PAICON Returns to DMEA as Nova Award Recipients
PAICON returned to DMEA 2026 as Nova Award recipients, showing a live demo of PaiX Navigator and announcing the book...
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.